15 JULY - To help reduce the number of adverse drug events, including deaths, from medication errors, FDA is developing a regulation requiring bar code labeling for human drug and biologic products.
MEETING TO DISCUSS BAR CODE LABELINGFOR DRUGS -- To help reduce the number ofadverse drug events, including deaths, frommedication errors, FDA is developing a regulationrequiring bar code labeling for human drug andbiologic products. The agency is holding a publicmeeting July 26 to solicit comments on theregulation.http://www.fda.gov/bbs/topics/NEWS/2002/NEW00821.html
Mastering Antibody-Drug Conjugates
December 19th 2024In this episode, we explore BIOVECTRA’s capabilities in antibody-drug conjugate (ADC) manufacturing, from complex conjugation chemistry to synthesis of highly potent payloads. We’ll also showcase how BIOVECTRA’s extensive experience in complex chemistries and specialized small molecule manufacturing gives them a unique perspective, strengthening their approach to ADC production and ensuring clients receive custom solutions across all project stages.